GRANT OF EXCLUSIVE MANUFACTURING RIGHTS Sample Clauses

GRANT OF EXCLUSIVE MANUFACTURING RIGHTS. Subject to the terms and provisions of Section 2.1(b), Grantor does hereby grant, sell, convey, transfer, assign and deliver to Manufacturer and its successors and assigns, free and clear of all liens, charges, claims, encumbrances or rights or interests of third parties of any nature and description whatsoever, exclusive rights to manufacture all and any private label brand cigarettes bearing the trademarks or any other trademarks or trade names owned, used or licensed now or hereafter by the Grantor ("Private Label Products") for a period commencing on the date hereof and continuing until the expiration of the Initial Term. (as defined in Section 4.1) or any later date to which this Agreement is extended pursuant to Section 4.1 hereof."
Sample 1
AutoNDA by SimpleDocs
GRANT OF EXCLUSIVE MANUFACTURING RIGHTS. During the term of this Agreement, IGI, subject to certain conditions herein provided for, shall have the exclusive right to manufacture the Initial DERMWORX Products and Potential Products. DERMWORX hereby grants a nonexclusive, world-wide, royalty-free, fully, paid-up, revocable license in and to all intellectual property rights it may now or in the future possess (including all patent, copyright, trade secret and know-how/show-how rights) that may be necessary for the purpose of manufacturing the Initial DERMWORX Products and Potential Products at the request of DERMWORX. Except as provided in Section 9.2.2 of this Agreement, during the term of this Agreement, DERMWORX shall not enter into any agreement or other arrangement with any person or entity other than IGI for the manufacture of the Initial DERMWORX Products and Potential Products, without the express prior written consent of IGI, which consent may be granted or withheld in IGI's sole discretion; provided, however, that in the event that IGI's production facility in Buena, New Jersey ("IGI Production Facility") does not have FDA approval to produce an Initial DERMWORX Product or Potential Product, IGI shall with <PAGE> 16 DERMWORX's cooperation locate and equip a facility with the requisite FDA approval to produce same pursuant to terms to be agreed by amendment to this Agreement.
Sample 1
GRANT OF EXCLUSIVE MANUFACTURING RIGHTS. Subject to the terms and provisions of Section 2.1(b), Parent, Licensor and C/M Products, each of them for themselves and for their respective affiliates, successors and assigns (collectively and individually, the "Grantor") do hereby grant, sell, coney, transfer, assign and deliver to Manufacturer, and its successors and assigns, free and clear of all liens, charges, claims, encumbrances or rights or interests of third parties of any nature and description whatsoever, exclusive rights to manufacture for sale and distribution in the United States all and any private label brand cigarettes bearing the Trademarks or any other trademarks or trade names owned or licensed now or hereafter by or to the Grantor in connection with such private label brand cigarettes ("Private Label Products") for a period commencing on and as of the date hereof and continuing until the termination of this Agreement as provided in Section 4.1 hereof.
Sample 1

Related to GRANT OF EXCLUSIVE MANUFACTURING RIGHTS

  • Grant of Exclusive License 1. Licensor hereby grants to Licensee an exclusive worldwide license with the right to sublicense others, to make, have made, use, sell and lease the Products described in the Licensed Patent Rights with reach-through rights reserved to Licensor.

  • Supply of Materials Unless the parties otherwise agree in a Work Order, Manufacturer will supply, in accordance with the relevant approved raw material specifications, all materials to be used by Manufacturer in the performance of Services under a Work Order other than the Rhythm Materials specified in such Work Order. Rhythm or its designees will provide Manufacturer with the Rhythm Materials. Manufacturer agrees (a) to account for all Rhythm Materials, (b) not to provide Rhythm Materials to any third party (other than an Affiliate acting as a permitted subcontractor) without the express prior written consent of Rhythm, (c) not to use Rhythm Materials for any purpose other than conducting the Services, including, without limitation, not to analyze, characterize, modify or reverse engineer any Rhythm Materials or take any action to determine the structure or composition of any Rhythm Materials unless required * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. pursuant to a signed Work Order, and (d) to destroy or return to Rhythm all unused quantities of Rhythm Materials according to Rhythm’s written directions.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • API A. Reliant shall supply to Cardinal Health for Manufacturing and Packaging, at Reliant’s sole cost, the API and applicable reference standards in quantities sufficient to meet Reliant’s requirements for each Product as further set forth in Article 4. Prior to delivery of any of the API or reference standard to Cardinal Health for Manufacturing and Packaging, Reliant shall provide to Cardinal Health a copy of the API Material Safety Data Sheet (“MSDS”), as amended, and any subsequent revisions thereto. Reliant shall supply the API, reference standards, and Certificate of Analysis FOB the Facility no later than thirty (30) days before the scheduled Manufacture Date upon which such API will be used by Cardinal Health. Upon receipt of the API, Cardinal Health shall conduct identification testing of the API. Cardinal Health shall use the API solely and exclusively for Manufacturing and Packaging under this Agreement. The maximum volume of API that Reliant supplies to Cardinal Health shall not exceed the amount reflected in the Firm Commitment and the next six (6) months of the Rolling Forecast.

  • Exclusive License Grant Subject to the terms and conditions of this Agreement, Licensee hereby grants to Takeda an exclusive, sublicensable (subject to Section 3.3 (Sublicensing)), royalty-bearing right and license under the Licensee Technology and Licensee’s interest in the Joint Technology to Exploit the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Field in the Takeda Territory.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Non-Exclusive License Grant Subject to the terms and conditions of this Agreement, Takeda hereby grants to Licensee a non-exclusive, sublicensable (subject to Section 3.3 (Sublicensing)) right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to: (a) Develop the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Men’s Health Field in the Takeda Territory solely for the purpose of Exploiting such Licensed Products in the Field in the Licensee Territory, or as required in order for Licensee to comply with its diligence obligations set forth in Section 5.2 (Development Diligence Obligations) and (b) Manufacture the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Takeda Territory.

Time is Money Join Law Insider Premium to draft better contracts faster.